Clinical use of microvolt T-wave alternans in patients with depressed left ventricular function eligible for ICD implantation: Mortality outcomes after long term follow-up

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 3038-3040

  Molon, Giulio ^a   Cohen, Richard J ^b   De Santo, Tiziana ^c   Costa, Alessandro ^a   Barbieri, Enrico ^a  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c Medtronic Italy Sesto SG   (Italy)

Author keywords

Implantable cardioverter defibrillator; Risk stratification; Sudden death; T wave alternans

Indexed keywords

AGED; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CAUSE OF DEATH; CONTROLLED STUDY; DEVICE INFECTION; EVENT FREE SURVIVAL; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; LETTER; MAJOR CLINICAL STUDY; MALE; MICROVOLT T WAVE ALTERNANS; NONISCHEMIC CARDIOMYOPATHY; PACEMAKER FAILURE; PRIORITY JOURNAL; RISK ASSESSMENT; SHOCK; SUDDEN CARDIAC DEATH; TREATMENT INDICATION;

IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; RISK STRATIFICATION; SUDDEN DEATH; T-WAVE ALTERNANS;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84885599678     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.04.133     Document Type: Article

References (9)

1. J.J. Goldberger, A.E. Buxton, and M. Cain Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks Circulation 123 21 2011 2423 2430
2. R. Tung, and C.D. Swerdlow Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely Circulation 120 10 2009 825 827
3. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 3 2005 225 237
4. M.R. Reynolds, D.J. Cohen, and A.D. Kugelmass The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators J Am Coll Cardiol 47 12 2006 2493 2497
5. K.R. Laurita, and D.S. Rosenbaum Cellular mechanisms of arrhythmogenic cardiac alternans Prog Biophys Mol Biol 97 2-3 2008 332 347
6. T. Klingenheben, M. Zabel, R.B. D'Agostino, R.J. Cohen, and S.H. Hohnloser Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure Lancet 356 9230 2000 651 652
7. S.H. Hohnloser, T. Ikeda, and R.J. Cohen Evidence regarding clinical use of microvolt T-wave alternans Heart Rhythm 6 3 Suppl. 2009 S36 S44
8. F.M. Merchant, T. Ikeda, and R.F. Pedretti Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death Heart Rhythm. 9 8 2012; Aug 1256 1264
9. G. Molon, D. Marangoni, and E. Barbieri Spontaneous ventricular tachycardia and fibrillation in a patient with a positive microvolt T wave alternans test and negative electrophysiological study Pacing Clin Electrophysiol 27 1 2004 120 122